The global carrier screening market is on a strong growth trajectory, with an estimated market size of US$ 1,343.40 million in 2023. Recent analysis forecasts the market to exhibit a compound annual growth rate (CAGR) of 12.4% from 2023 to 2033, reaching an anticipated value of approximately US$ 4,323.84 million by the end of the forecast period.
This growth is primarily driven by advancements in genetic testing technologies and increasing awareness of the benefits of carrier screening for prospective parents.
Market Outlook: As awareness of genetic screening continues to expand and technologies advance, the carrier screening market is well-positioned for robust growth over the next decade. With a commitment to improving health outcomes through early detection and prevention, the market is set to thrive through 2033.
Key Market Drivers:
- Advancements in Genetic Testing: Continuous innovations in genetic testing methods are making carrier screening more accessible and accurate. These advancements are crucial for identifying potential genetic disorders in unborn children, thus driving market growth.
- Growing Awareness and Acceptance: Increasing awareness among healthcare professionals and prospective parents about the importance of carrier screening is contributing to its rising adoption. This awareness is further supported by educational campaigns and resources highlighting the benefits of early detection and informed reproductive choices.
- Rising Prevalence of Genetic Disorders: The growing incidence of genetic disorders has prompted healthcare providers to recommend carrier screening as a proactive measure, leading to heightened demand for screening services.
Regional Insights: North America is expected to lead the carrier screening market, driven by advanced healthcare infrastructure, significant investment in genetic research, and widespread adoption of personalized medicine. Europe is also projected to maintain a substantial share, while the Asia-Pacific region is anticipated to witness rapid growth due to increasing healthcare access and advancements in genetic testing technologies.
How Competition Influences the Carrier Screening Market?
To expand the carrier screening market globally, businesses and service providers are using tactics including technological development and discovery, vertical collaboration, building a strong product portfolio through startups, mergers and acquisitions, and regional expansion.
Key Players
- Myriad Genetics, Inc
- Cepheid
- Illumina
- Thermo Fisher Scientific Inc.
- F.Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Otogenetics
- MedGenome
- GeneTech
- Centogene N.V.
Key Segments
By Type:
- Expanded Carrier Screening
- Targeted Disease Carrier Screening
By Medical Condition:
- Cystic Fibrosis
- Tay-Sachs
- Gaucher Disease
- Sickle Cell Disease
- Spinal Muscular Atrophy
- Other
By Technology:
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Other
By End User:
- Hospitals
- Laboratories
- Physician Offices & Clinics
- Other
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
